Boothbay Fund Management LLC acquired a new stake in Arteris, Inc. (NASDAQ:AIP - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 51,575 shares of the company's stock, valued at approximately $526,000. Boothbay Fund Management LLC owned 0.13% of Arteris as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. US Bancorp DE grew its holdings in shares of Arteris by 29.0% during the fourth quarter. US Bancorp DE now owns 5,702 shares of the company's stock worth $58,000 after purchasing an additional 1,283 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Arteris during the fourth quarter worth about $64,000. Price T Rowe Associates Inc. MD bought a new position in shares of Arteris during the fourth quarter valued at approximately $117,000. SG Americas Securities LLC bought a new stake in shares of Arteris during the 4th quarter valued at about $134,000. Finally, Wells Fargo & Company MN grew its holdings in shares of Arteris by 38.9% during the 4th quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock worth $134,000 after acquiring an additional 3,694 shares during the period. 64.36% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of brokerages have recently commented on AIP. Northland Securities boosted their price target on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 19th. Rosenblatt Securities reissued a "buy" rating and set a $15.00 price objective on shares of Arteris in a research report on Tuesday, February 18th.
Check Out Our Latest Analysis on Arteris
Insider Activity
In other news, COO Laurent R. Moll sold 4,703 shares of the firm's stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total value of $33,485.36. Following the completion of the sale, the chief operating officer now owns 482,833 shares in the company, valued at approximately $3,437,770.96. This trade represents a 0.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO K Charles Janac sold 50,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $10.33, for a total value of $516,500.00. Following the transaction, the chief executive officer now owns 9,907,691 shares of the company's stock, valued at approximately $102,346,448.03. The trade was a 0.50 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 100,927 shares of company stock worth $918,829 over the last quarter. Insiders own 33.70% of the company's stock.
Arteris Price Performance
NASDAQ:AIP traded up $0.10 during trading hours on Friday, hitting $6.72. 147,733 shares of the stock traded hands, compared to its average volume of 198,939. The stock has a 50 day moving average price of $7.07 and a 200 day moving average price of $8.61. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. The company has a market cap of $278.63 million, a price-to-earnings ratio of -7.72 and a beta of 1.31. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $12.64.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). The business had revenue of $15.49 million during the quarter, compared to analysts' expectations of $15.34 million. Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. Sell-side analysts forecast that Arteris, Inc. will post -0.73 EPS for the current fiscal year.
Arteris Profile
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.